¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"anticoagulant sodium citrate solution"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® sodium ÇÑ±Û ³ªÆ®·ý
¼³¸í   
  ¿øÀÚ¹øÈ£ 11ÀÇ ±Ý¼Ó¿øÀÚ. ¼¼Æ÷ ¿Ü¾×ÀÇ °¡Àå ÈçÇÑ ¾çÀÌ¿ÂÀ¸·Î¼­ ¼¼Æ÷ ¿Ü¾×ÀÇ »ïÅõ¾Ð°áÁ¤¿¡ °¡Àå Áß¿äÇÑ ¿ªÇÒÀ» ÇÔ. ¾Ëµµ½ºÅ×·Ð(aldosterone: ÄáÆÏÀ§¿¡ Àִ ºÎ½Å¿¡¼­ ºÐºñÇÑ´Ù. Ç÷¾×³»ÀÇ »ïÅõ¾ÐÀ¯Áö¿¡ Áß¿äÇÑ ÀÛ¿ëÀ» ÇÑ´Ù)¿¡ ÀÇÇØ ÄáÆÏ¿¡¼­ ÀçÈí¼ö°¡ ÃËÁøµÇ¸ç Ã¼³» ¼öºÐ·®À» °áÁ¤Çϴ °¡Àå Áß¿äÇÑ ÀÎÀÚ. ½Å°æ¼¼Æ÷ µîÀÇ ÈïºÐ¼º ¼¼Æ÷ÀÇ ÈïºÐ½Ã ¼¼Æ÷³»·Î À¯ÀԵǾî ÈïºÐÀ» À¯¹ßÇϴ Áß¿äÇÑ ±â´Éµµ °¡Áø´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • citrate
    ½ÃÆ®¸£»ê¿°, ±¸¿¬»ê¿°
  • clomiphene citrate
    Ŭ·Î¹ÌÆæ½ÃÆ®¸£»ê¿°, Ŭ·Î¹ÌÆæ±¸¿¬»ê¿°
  • Simmons citrate agar
    ½Ã¸Õ½º½ÃÆ®¸£»ê¿ì¹«¹èÁö
  • anticoagulant
    1. Ç×ÀÀ°í- 2. Ç×ÀÀ°íÁ¦
  • anticoagulant drug
    Ç×ÀÀ°íÁ¦
  • anticoagulant effect
    Ç×ÀÀ°íÈ¿°ú
  • lupus anticoagulant
    ·çǪ½ºÇ×ÀÀ°íÀÎÀÚ
  • exchangeable sodium
    ±³È¯°¡´É³ªÆ®·ý
  • sodium
    ³ªÆ®·ý
  • sodium bicarbonate
    Áßź»ê¿°³ªÆ®·ý
  • sodium channel
    ³ªÆ®·ýÅë·Î
  • sodium chloride
    ¿°È­³ªÆ®·ý
  • sodium iodide
    ¿ä¿ÀµåÈ­³ªÆ®·ý
  • sodium pump
    ³ªÆ®·ýÆßÇÁ
  • sodium-potassium pump
    ³ªÆ®·ýÄ®·ýÆßÇÁ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • citrate
    ±¸¿¬»ê, ½ÃÆ®¸£»ê¿°
  • clomiphene citrate
    ±¸¿¬»êŬ·Î¹ÌÆæ
  • anticoagulant
    Ç×ÀÀ°í-, Ç×ÀÀ°íÁ¦
  • anticoagulant drug
    Ç×ÀÀ°íÁ¦
  • anticoagulant effect
    Ç×ÀÀ°íÈ¿°ú
  • sodium bicarbonate
    Áßź»ê¿°³ªÆ®·ý
  • sodium channel
    ³ªÆ®·ýÅë·Î
  • sodium chloride
    ¿°È­³ªÆ®·ý
  • sodium
    ³ªÆ®·ý
  • solution
    ¿ë¾×
  • balanced salt solution
    ÆòÇü¿°¾×
  • buffer solution
    ¿ÏÃæ¾×
  • hypotonic solution
    ÀúÀå¾×, ³·Àº»ïÅõ¾Ð¿ë¾×
  • Lugol's solution
    ·ç°ñ¿ë¾×
  • physiological salt solution
    »ý¸®½Ä¿°¼ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • simmons citrate agar
    ½Ã¸ó½º±¸¿¬»ê¿ì¹«
  • citrate
    ±¸¿¬»ê, ½ÃÆ®¸£»ê¿°
  • anticoagulant
    Ç×ÀÀ°í-, Ç×ÀÀ°íÁ¦
  • anticoagulant drug
    Ç×ÀÀ°íÁ¦
  • anticoagulant effect
    Ç×ÀÀ°íÈ¿°ú
  • anticoagulant lupus
    ·çǪ½ºÇ×ÀÀ°íÀÎÀÚ
  • sodium channel
    ³ªÆ®·ýÅë·Î
  • sodium chloride
    ¿°È­³ªÆ®·ý
  • exchangeable sodium
    ±³È¯³ªÆ®·ý
  • sodium iodide
    ¿ä¿ÀµåÈ­³ªÆ®·ý
  • sodium-potassium pump
    ³ªÆ®·ýÄ®·ýÆßÇÁ
  • sodium
    ³ªÆ®·ý
  • alkaline solution
    ¾ËÄ®¸®¿ë¾×
  • anisotonic solution
    ºñµîÀå¾×
  • aqueous solution
    ¼ö¾ç¾×, ¹°¿ë¾×
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acid citrate dextrose
    »ê ±¸¿¬»ê¿°Æ÷µµ´ç
  • fractional sodium excretion
    ºÐȹ¼º³ªÆ®·ý¹è¼³
  • hexobarbital sodium
    Çí»ç¹Ù¸£ºñÅ»³ªÆ®·ý.
  • phethenylate sodium
    ÆäÅ×´Ò·¹ÀÌÆ®³ªÆ®·ý.
  • anticoagulant
    Ç×ÀÀ°íÁ¦(ù÷ëêͳð¥), Ç×ÀÀ°í¼º(¡­ëêͳàõ)
  • anticoagulant
    Ç×ÀÀ°í¾à<Á¦>, Ç×ÀÀ°í¼ºÀÇ.
  • anticoagulant drug
    Ç×ÀÀ°íÁ¦.
  • anticoagulant effect
    Ç×ÀÀ°íÈ¿°ú.
  • anticoagulant therapy
    Ç×ÀÀ°í¿ä¹ý.
  • Alsevers solution
    ¾Ù¼­¹ö¿ë¾× (¸é¾çÇ÷¾×º¸Á¸¾×)
  • Calots solution
    Ä®·Î¾×.
  • Chameleon solution
    Ä«¸á·¹¿Â¿ë¾×.
  • Channings solution
    Âù´×¾×.
  • Chenzinsky-Plein solution
    þÁø½ºÅ²-Ç÷¹Àο°»ö¾×.
  • Earies solution
    Earle¿ë¾×
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cetrimide-citrate-saline solution
    ¼¼Æ®¸®¹ÌÀ̵å-±¸¿¬»ê-½Ä¿° ¿ë¾×
  • isotonic sodium chloride solution
    »ý¸®½Ä¿°¾×(ßæìµãÝç¤äû), »ý½Ä¼ö(ßæãÝâ©) .
  • meralluride sodium solution
    ¸Þ¶ö·ç¶óÀ̵峪Ʈ·ýÁÖ»ç¾×(¡­ñ¼ÞÒäû).
  • sodium lactate solution, Hartmann
    Á£»ê³ªÆ®·ý¿ë¾×, Çϸ£Æ®¸¸¿ë¾×, À¯»ê³ªÆ® ·ý¿ë¾×.
  • anticoagulant
    Ç×ÀÀ°í¾à<Á¦>, Ç×ÀÀ°í¼ºÀÇ.
  • anticoagulant
    Ç×ÀÀ°íÁ¦(ù÷ëêͳð¥), Ç×ÀÀ°í¼º(¡­ëêͳàõ)
  • anticoagulant drug
    Ç×ÀÀ°íÁ¦.
  • anticoagulant effect
    Ç×ÀÀ°íÈ¿°ú.
  • anticoagulant therapy
    Ç×ÀÀ°í¿ä¹ý.
  • lupus anticoagulant
    ·çǪ½ºÇ×ÀÀ°í¹°Áú
  • lupus anticoagulant
    ·çǪ½ºÇ×ÀÀ°íÀÎÀÚ
  • lupus anticoagulant
    ·çÇÁ½º Ç×ÀÀ°íÁ¦(¡­ ù÷ëêͳð¥)
  • lupus anticoagulant syndrome
    ·çÇÁ½º Ç×ÀÀ°íÁ¦ ÁõÈıº
  • lupus-like anticoagulant
    ·çǪ½º¾ç Ç×ÀÀ°íÀÎÀÚ
  • oral anticoagulant
    °æ±¸Ç×ÀÀÇ÷¾à(ÌèÏ¢ù÷ ëêúìå·).
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Schaudinn's solution
    »þ¿ìµò°íÁ¤¾×
  • sodium antimony gluconate
    ¾ÈƼ¸ó±Û·çÄڻ곪Ʈ·ý
  • sodium stibogluconate
    ±Û·çÄڻ곪Ʈ·ý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acid-citrate-dextrose solution
    »ê(ß«)-½ÃÆ®¸£»ê-(ß«)µ¦½ºÆ®·Î½º ¿ë¾×(éÁäû)
  • anticoagulant
    Ç×ÀÀ°íÁ¦(ù÷ëêͳð¥)
  • sodium azide
    ¾ÆÁöµåÈ­(ûù) ³ªÆ®¸®¿ò
  • sodium dodecyl sulfate
    µµµ¥½ÇȲ»ê(üÜß«) ³ªÆ®¸®¿ò
  • sodium dodecyl sulfate polyacrylamide gel electrophoresis
    µµµ¥½Ç Ȳ»ê(üÜß«) ³ªÆ®¸®¿ò Æú¸®¾ÆÅ©¸±¾Æ¸¶À̵å Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ)
  • sodium error
    ¼Òµð¿ò ¿ÀÂ÷(è¦ó¬)
  • sodium lauryl sulfate
    ¶ó¿ì¸± Ȳ»ê ³ªÆ®¸®¿ò
  • sodium pentobarbital
    ÆæÅä¹Ù¸£ºñÅ» ³ªÆ®¸®¿ò
  • sodium pump
    ¼Òµð¿ò ÆßÇÁ
  • citrate-activated thrombin
    ½ÃÆ®¸£»êȰ¼º(ß«üÀàõ) Æ®·Òºó
  • citrate cleavage enzyme
    ½ÃÆ®¸£»êÀý´ÜÈ¿¼Ò(ï·Ó¨ý£áÈ)
  • citrate cycle
    ½ÃÆ®¸£»êȸ·Î(ß«üÞÖØ)
  • citrate lyase
    ½ÃÆ®¸£»ê(ß«) ¶óÀÌ¿¡À̽º
  • citrate-pyruvate cycle
    ½ÃÆ®¸£»ê(ß«)-ÇǸ£ºê»êȸ·Î(ß«üÞÖØ)
  • citrate synthase
    ½ÃÆ®¸£»ê(ß«) ½ÅÅ×À̽º
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anticoagulant
    Ç×ÀÀ°í¾àÁ¦, Ç×ÀÀ°í¼ºÀÇ
  • sodium
    ³ªÆ®·ý
  • anisotonic solution
    ºñµîÀå¾×
  • replenisher solution
    Áõ¾×
  • s solution
    ¸µ°Å¾×
  • solution
    ¿ë¾×, ¿ë»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ACD absolute cardiac dullness; absolute claudication distance; acid-citrate-dextrose [solution]; actinom...
SSC single-strand conformational [analysis]; sister strand crossover; somatosensory cortex; standard sal...
PSL parasternal line; photostimulable luminescence; potassium, sodium chloride, and sodium lactate [solu...
SS disulfide; sacrosciatic; saline soak; saline solution; saliva sample; saliva substitute; Salmonella-...
SC conditioned stimulus; sacrococcygeal; Sanitary Corps; scalenus [muscle]; scapula; Schwann cell; scia...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AC Anticoagulant
LAC Lupus AntiCoagulant
OAC Oral anticoagulant
OAT Oral anticoagulant therapy
r-TAP Recombinant tick anticoagulant peptide
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • sodium citrate
    ±¸¿¬»ê ³ªÆ®·ý
    C6H5Na3O7. ±¸¿¬»êÀÇ »ï³ªÆ®·ý¿°.
  • cetrimide-citrate-saline solution
    ¼¼Æ®¸®¹ÌÀ̵å-±¸¿¬»ê-½Ä¿° ¿ë¾×
  • Harlmann sodium lactate solution
    Á¥»ê ³ªÆ®·ý ¿ë¾×, Çϸ£Æ®¸¸ ¿ë¾×, À¯»ê ³ªÆ®·ý ¿ë¾×
  • anticoagulant
    Ç×ÀÀ°í¾à, Ç×ÀÀ°í¼ºÀÇ, Ç×ÀÀ°íÁ¦
    Ç÷¾×ÀÇ ÀÀ°í¸¦ ¸·´Â ¹°Áú. Those administered for
  • anticoagulant drug
    Ç×ÀÀ°íÁ¦
    Ç÷¾×ÀÇ ÀÀ°í¸¦ ¸·´Â ¾àÁ¦.
  • anticoagulant therapy
    Ç×ÀÀ°í Ä¡·á, Ç×ÀÀ°í ¿ä¹ý
  • circulating anticoagulant
    ¼øÈ¯¼º Ç×ÀÀ°íÁ¦
  • citrate test
    ±¸¿¬»ê¿° ½ÃÇè
  • magnesium citrate
    ±¸¿¬»ê ¸¶±×³×½·
    ¹é»ö, ¹«ÃëÀÇ °áÀý¼º ºÐ¸».
  • oral anticoagulant
    °æ±¸ Ç×ÀÀÇ÷ ¾à
  • tamoxifen citrate
    ±¸¿¬»ê Ÿ¸ñ½ÃÆæ
    ºñ½ºÅ×·ÎÀ̵åÀÇ Ç׿¡½ºÆ®·ÎÁ¨ ¾à¹°À̸ç, Æó°æ±â ¿©¼ºÀÇ À¯¾Ï Ä¡·á¿¡ »ç¿ëÇϱ⵵ Çϸç, ¶ÇÇÑ ºÒÀÓÁõ¿¡¼­ ¹è¶õÀ» ÀÚ±ØÇϱâ À§ÇÏ¿©¼­µµ »ç¿ëÇÑ´Ù.
  • aldosterone-mediated sodium
    ¾Ëµµ½ºÅ×·Ð Áß°³µÈ ³ªÆ®·ý
  • barbital sodium
    ¹Ù¸£ºñÅ» ³ªÆ®·ý
  • butabarbital sodium
    ºÎŸ¹Ù¸£ºñÅ» ³ªÆ®·ý
    ÁøÁ¤ ¹× ¼ö¸éÁ¦·Î »ç¿ëÇÏ°í °æ±¸ÀûÀ¸·Î Åõ¿©ÇÑ´Ù.
  • dextrothyroxine sodium
    µ¦½ºÆ®·ÎŸÀ̷ϽгªÆ®·ý
    thyroxineÀÇ ¿ì¼±¼º À̼ºÃ¼ÀÇ ³ªÆ®·ý ¿°. ´ãȲ»öÀÇ ºÐ¸». °úÄÝ·¹½ºÅ×·ÑÇ÷ÁõÀÇ Ä¡·á¿¡ »ç¿ëÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
anticoagulant <haematology, pharmacology> Any substance that prevents blood clotting.
Those drugs administered for prophylaxis or treatment of thromboembolic disorders are heparin, which inactivates thrombin and several other clotting factors and which must be administered parenterally and the oral anticoagulants (warfarin, dicumarol and congeners) which inhibit the hepatic synthesis of vitamin K dependent clotting factors.
Anticoagulant solutions used for the preservation of stored whole blood and blood fractions are acid citrate dextrose (ACD), citrate phosphate dextrose (CPD), citrate phosphate dextrose adenine (cPDA 1) and heparin.
Anticoagulants used to prevent clotting of blood specimens for laboratory analysis are heparin and several substances that make calcium ions unavailable to the clotting process, including EDTA (ethylenediaminetetraacetic acid), citrate, oxalate and fluoride.
(18 Nov 1997)
anticoagulant therapy The use of anticoagulant drugs to reduce or prevent intravascular or intracardiac clotting.
(05 Mar 2000)
vascular anticoagulant <protein> Group of calcium-binding proteins that interact with acidic membrane phospholipids in membranes. They contain 4 or 8 repeats of a 61 amino acid domain that folds into 5 a helices.
Also known by several other names (e.g. Lipocortins, endonexins), reflecting the history of their discovery in different contexts.
See: lipocortin, endonexin I & II, calpactin, p70 and calelectrin.
(18 Nov 1997)
lupus anticoagulant An immunoglobulin that interferes with blood coagulation and has antithromboplastin activity. This immunoglobulin can prolong blood clotting and occurs in approximately 25% of people with lupus.
(27 Sep 1997)
sodium acid citrate Na3C6H5O7 -2H2O; trisodium citrate;used as diuretic, antilithic, systemic and urinary alkaliser, expectorant, and anticoagulant (in vitro).
Synonym: sodium acid citrate.
(05 Mar 2000)
sodium citrate Na3C6H5O7 -2H2O; trisodium citrate;used as diuretic, antilithic, systemic and urinary alkaliser, expectorant, and anticoagulant (in vitro).
Synonym: sodium acid citrate.
(05 Mar 2000)
sodium citrate acid C6H6O7Na-11/2H2O; disodium hydrogen citrate;same actions and uses as sodium citrate; in addition, it may be used in solutions of glucose without producing caramelization of the latter during autoclaving.
(05 Mar 2000)
acid-citrate-dextrose A citrate anticoagulant used for the collection and preservation of whole blood. It has largely been replaced by newer coagulants (CPD, Adsol) that allow for longer shelf life for blood and blood products.
Acronym: ACD
(05 Mar 2000)
ATP citrate lyase ATP citrate (pro-3S)-lyase
ATP citrate (pro-3S)-lyase <enzyme> An enzyme that, in the presence of ATP and CoA, catalyses the cleavage of citrate to yield acetyl CoA, oxaloacetate, ADP, and orthophosphate. This reaction represents an important step in fatty acid biosynthesis.
Chemical name: ATP:citrate oxaloacetate-lyase ((pro-S)-CH2COO(-)--acetyl-CoA) (ATP-dephosphorylating)
Registry number: EC 4.1.3.8
Synonym: citrate cleavage enzyme.
(12 Dec 1998)
bismuth ammonium citrate Ammoniocitrate of bismuth; an intestinal astringent.
(05 Mar 2000)
bismuth citrate Used in the making of bismuth and ammonium citrate.
(05 Mar 2000)
caffeine citrate Citrated caffeine, a mixture of equal parts of caffeine and citric acid.
(05 Mar 2000)
calcium citrate <chemical> A colourless crystalline or white powdery organic, tricarboxylic acid occurring in plants, especially citrus fruits, and used as a flavoring agent, as an antioxidant in foods, and as a sequestrating agent.
Pharmacological action: antioxidants.
(12 Dec 1998)
carbetapentane citrate 2-(Diethylaminoethoxy)ethyl 1-phenylcyclopentyl-1-carboxylate citrate;it has atropine-like and local anaesthetic actions and effectively suppresses acute cough due to common upper respiratory infections.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anticoagulant
    Ç×ÀÀÇ÷¾à(ÀÇ)
  • citrate
    ±¸¿¬»ê¿°
  • solution
    ÇØ°á
  • Ringer's solution
    ¸µ°Å¾×
  • final solution
    ÃÖÁ¾Àû ÇØ°á
  • fixing solution
    Á¤Âø¾×
  • normal solution
    ±ÔÁ¤¾×
  • physiological salt solution
    »ý¸®Àû ½Ä¿°¼ö o
  • saturated solution
    Æ÷È­ ¿ë¾×
  • solution
    ÇØ°á;ÇØ¸í;¿ëÇØ;¿ë¾×;ºÐ¸®
  • sodium
    ³ªÆ®·ý
  • cormolyn sodium
    Å©·Î¸ô¸° ³ªÆ®·ý(±â°üÁö È®ÀåÁ¦)
  • pentobarbital sodium
    ÆæÅä¹Ù¸£ºñÅ» ³ªÆ®·ý(´Ü½Ã°£Çü ÁøÁ¤,ÃÖ¸é,ÁøÅë¾à)
  • sodium
    ³ªÆ®·ý(±Ý¼Ó ¿ø¼Ò,±âÈ£ Na)
  • sodium bicarbonate
    Áßź»ê³ªÆ®·ý 
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á